Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Investors Hype Senior Housing At Goodwin Conference No Photo Available

Charlie Innis

In what might be a sign of the times, housing and medical care facilities for elderly baby boomers shared the spotlight as today's mos... (more story)

A Look At The Real Impact Of The FTC's PBM Settlements No Photo Available

Yeji Jesse Lee

It may all come down to the details in a landmark settlement between the Federal Trade Commission and one of the biggest pharmacy bene... (more story)

Minn. Medicaid Funds Case A Test For CMS Tactic No Photo Available

Dan McKay

Minnesota’s fight over $243 million in Medicaid funding frozen by the Trump administration sets up an unusual, politically tinged lega... (more story)